These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25230329)

  • 21. Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A.
    Cowardin CA; Jackman BM; Noor Z; Burgess SL; Feig AL; Petri WA
    Infect Immun; 2016 Aug; 84(8):2317-2323. PubMed ID: 27271747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation.
    Bobo LD; El Feghaly RE; Chen YS; Dubberke ER; Han Z; Baker AH; Li J; Burnham CA; Haslam DB
    Infect Immun; 2013 Mar; 81(3):713-22. PubMed ID: 23264053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile, the Difficult "Kloster" Fuelled by Antibiotics.
    Dicks LMT; Mikkelsen LS; Brandsborg E; Marcotte H
    Curr Microbiol; 2019 Jun; 76(6):774-782. PubMed ID: 30084095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis.
    Jarchum I; Liu M; Lipuma L; Pamer EG
    Infect Immun; 2011 Apr; 79(4):1498-503. PubMed ID: 21245274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China.
    Zhou FF; Wu S; Klena JD; Huang HH
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1773-9. PubMed ID: 24820293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate
    Maseda D; Zackular JP; Trindade B; Kirk L; Roxas JL; Rogers LM; Washington MK; Du L; Koyama T; Viswanathan VK; Vedantam G; Schloss PD; Crofford LJ; Skaar EP; Aronoff DM
    mBio; 2019 Jan; 10(1):. PubMed ID: 30622186
    [No Abstract]   [Full Text] [Related]  

  • 27. Circulating antibody and memory B-Cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis.
    Monaghan TM; Robins A; Knox A; Sewell HF; Mahida YR
    PLoS One; 2013; 8(9):e74452. PubMed ID: 24058568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
    Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
    Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile colitis acquired in the intensive care unit: outcome and prognostic factors.
    Sabau L; Meybeck A; Gois J; Devos P; Patoz P; Boussekey N; Delannoy PY; Chiche A; Georges H; Leroy O
    Infection; 2014 Feb; 42(1):23-30. PubMed ID: 23780568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
    Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
    World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
    Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
    mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
    Fletcher JR; Pike CM; Parsons RJ; Rivera AJ; Foley MH; McLaren MR; Montgomery SA; Theriot CM
    Nat Commun; 2021 Jan; 12(1):462. PubMed ID: 33469019
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Jenior ML; Leslie JL; Young VB; Schloss PD
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29950381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
    Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW
    Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of interleukin 23 signaling in Clostridium difficile colitis.
    Buonomo EL; Madan R; Pramoonjago P; Li L; Okusa MD; Petri WA
    J Infect Dis; 2013 Sep; 208(6):917-20. PubMed ID: 23776194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strain-Dependent Inhibition of Clostridioides difficile by Commensal
    Reed AD; Nethery MA; Stewart A; Barrangou R; Theriot CM
    J Bacteriol; 2020 May; 202(11):. PubMed ID: 32179626
    [No Abstract]   [Full Text] [Related]  

  • 37. Neutralization of macrophage migration inhibitory factor improves host survival after Clostridium difficile infection.
    Jose S; Mukherjee A; Abhyankar MM; Leng L; Bucala R; Sharma D; Madan R
    Anaerobe; 2018 Oct; 53():56-63. PubMed ID: 29944928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of Clostridium difficile-suspected diarrhea in a French university hospital.
    Khanafer N; Vanhems P; Barbut F; Eckert C; Perraud M; Vandenesch F; Luxemburger C; Demont C;
    Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2123-2130. PubMed ID: 30120646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Need for clinicopathologic correlation of Clostridium difficile colitis in view of molecular diagnosis.
    Guarner J; Kraft CS
    Clin Infect Dis; 2012 Jan; 54(1):156. PubMed ID: 22187416
    [No Abstract]   [Full Text] [Related]  

  • 40. Murine models to study Clostridium difficile infection and transmission.
    Lawley TD; Young VB
    Anaerobe; 2013 Dec; 24():94-7. PubMed ID: 24076318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.